Your browser doesn't support javascript.
loading
Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
Jensen, Poul Erik H; Warnke, Clemens; Ingenhoven, Kathleen; Piccoli, Luca; Gasis, Marcia; Hermanrud, Christina; Fernandez-Rodriguez, Blanca M; Ryner, Malin; Kramer, Daniel; Link, Jenny; Ramanujam, Ryan; Auer, Michael; Buck, Dorothea; Grummel, Verena; Bertotti, Elisa; Fissolo, Nicolas; Oliver-Martos, Begoña; Nytrova, Petra; Khalil, Michael; Guger, Michael; Rathmaier, Sandra; Sievers-Stober, Claudia; Lindberg, Raija L P; Hässler, Signe; Bachelet, Delphine; Aktas, Orhan; Donnellan, Naoimh; Lawton, Andy; Hemmer, Bernhard; Havrdova, Eva Kubala; Kieseier, Bernd; Hartung, Hans-Peter; Comabella, Manuel; Montalban, Xavier; Derfuss, Tobias; Sellebjerg, Finn; Dönnes, Pierre; Pallardy, Marc; Spindeldreher, Sebastian; Broët, Philippe; Deisenhammer, Florian; Fogdell-Hahn, Anna; Sorensen, Per Soelberg.
Afiliação
  • Jensen PEH; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: poul.erik.h.jensen@regionh.dk.
  • Warnke C; Department of Neurology, University Hospital Köln, Köln, Germany; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany. Electronic address: clemens.warnke@uk-koeln.de.
  • Ingenhoven K; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany. Electronic address: Kathleen.Ingenhoven@med.uni-duesseldorf.de.
  • Piccoli L; Università della Svizzera italiana (USI), Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Bellinzona, Switzerland. Electronic address: luca.piccoli@irb.usi.ch.
  • Gasis M; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany. Electronic address: gasis@hhu.de.
  • Hermanrud C; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Electronic address: christina.hermanrud@ki.se.
  • Fernandez-Rodriguez BM; Università della Svizzera italiana (USI), Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Bellinzona, Switzerland. Electronic address: blanca.fernandez@irb.usi.ch.
  • Ryner M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Kramer D; Sanofi-Aventis Germany, Frankfurt Am Main, Germany. Electronic address: daniel.kramer@sanofi.com.
  • Link J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Electronic address: jenny.link@ki.se.
  • Ramanujam R; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; KTH - Royal Institute of Technology, Stockholm, Sweden. Electronic address: Ryan.Ramanujam@ki.se.
  • Auer M; Innsbruck Medical University, Innsbruck, Austria. Electronic address: Michael.Auer@student.i-med.ac.at.
  • Buck D; Department of Neurology, Technische Universität München, Munich, Germany. Electronic address: dorothea.buck@tum.de.
  • Grummel V; Department of Neurology, Technische Universität München, Munich, Germany. Electronic address: v.grummel@tum.de.
  • Bertotti E; Merck NBE Bioanalytics Ivrea, Colleretto Giacosa, Italy. Electronic address: elisa.bertotti@merckgroup.com.
  • Fissolo N; Hospital Universitari Vall d'Hebron, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain. Electronic address: nicolas.fissolo@vhir.org.
  • Oliver-Martos B; Hospital Regional Universitario de Málaga, Instituto de investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain.
  • Nytrova P; MS Center, Department of Neurology and Center Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic. Electronic address: Petra.Nytrova@lf1.cuni.cz.
  • Khalil M; Department of Neurology, Medical University of Graz, Graz, Austria. Electronic address: michael.khalil@medunigraz.at.
  • Guger M; Clinic for Neurology 2, Kepler University Clinic, Med Campus III, Linz, Austria. Electronic address: Michael.Guger@kepleruniklinikum.at.
  • Rathmaier S; Clinic for Neurology 2, Kepler University Clinic, Med Campus III, Linz, Austria. Electronic address: Sandra.Rathmaier@kepleruniklinikum.at.
  • Sievers-Stober C; Departments of Biomedicine and Neurology, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: claudia.sievers-stober@unibas.ch.
  • Lindberg RLP; Departments of Biomedicine and Neurology, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: Raija.Lindberg@unibas.ch.
  • Hässler S; CESP, INSERM UMR 1018, Faculty of Medicine, Paris-Sud University, Paris-Saclay, University UVSQ, Villejuif, France. Electronic address: signe.hassler@inserm.fr.
  • Bachelet D; CESP, INSERM UMR 1018, Faculty of Medicine, Paris-Sud University, Paris-Saclay, University UVSQ, Villejuif, France. Electronic address: delphine.bachelet@inserm.fr.
  • Aktas O; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany. Electronic address: orhan.aktas@uni-duesseldorf.de.
  • Donnellan N; Ipsen Biopharm Ltd., Berkshire, United Kingdom.
  • Lawton A; GlaxoSmithKline R&D, Uxbridge, Middlesex, United Kingdom. Electronic address: andy.m.lawton@gsk.com.
  • Hemmer B; Department of Neurology, Technische Universität München, Munich, Germany; Munich Cluster for systems Neurology (SyNergy), Munich, Germany. Electronic address: hemmer@lrz.tu-muenchen.de.
  • Havrdova EK; MS Center, Department of Neurology and Center Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic. Electronic address: eva.havrdova@lf1.cuni.cz.
  • Kieseier B; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany. Electronic address: Bernd.Kieseier@uni-duesseldorf.de.
  • Hartung HP; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany. Electronic address: hans-peter.hartung@uni-duesseldorf.de.
  • Comabella M; Hospital Universitari Vall d'Hebron, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain. Electronic address: manuel.comabella@vhir.org.
  • Montalban X; Hospital Universitari Vall d'Hebron, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain. Electronic address: xavier.montalban@unic-em.com.
  • Derfuss T; Departments of Biomedicine and Neurology, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: Tobias.Derfuss@usb.ch.
  • Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: finn.thorup.sellebjerg@regionh.dk.
  • Dönnes P; SciCross AB, Skövde, Sweden. Electronic address: pierre@scicross.com.
  • Pallardy M; INSERM UMR 996, Univ. Paris-Sud, Faculty of Pharmacy, Université Paris-Saclay, Châtenay-Malabry, France. Electronic address: marc.pallardy@u-psud.fr.
  • Spindeldreher S; Drug Metabolism Pharmacokinetics-Biologics, Novartis Institutes for Biomedical Research, Basel, Switzerland. Electronic address: sebastian.spindeldreher@novartis.com.
  • Broët P; CESP, INSERM UMR 1018, Faculty of Medicine, Paris-Sud University, Paris-Saclay, University UVSQ, Villejuif, France; Assistance Publique - Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France. Electronic address: philippe.broet@inserm.fr.
  • Deisenhammer F; Innsbruck Medical University, Innsbruck, Austria. Electronic address: Florian.Deisenhammer@tirol-kliniken.at.
  • Fogdell-Hahn A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Electronic address: Anna.Fogdell-Hahn@ki.se.
  • Sorensen PS; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: Per.Soelberg.Soerensen@regionh.dk.
J Neuroimmunol ; 326: 19-27, 2019 01 15.
Article em En | MEDLINE | ID: mdl-30447419

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Anticorpos Neutralizantes / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Anticorpos Neutralizantes / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article